Literature DB >> 17000942

Physician communication when prescribing new medications.

Derjung M Tarn1, John Heritage, Debora A Paterniti, Ron D Hays, Richard L Kravitz, Neil S Wenger.   

Abstract

BACKGROUND: Communication about taking a new medication is critical to proper use of drug therapy and to patient adherence. Despite ample evidence that medications are not taken as prescribed, few investigations have detailed the elements of communication about new medication therapy. This article describes and assesses the quality of physician communication with patients about newly prescribed medications.
METHODS: This was an observational study that combined patient and physician surveys with transcribed audiotaped office visits from 185 outpatient encounters with 16 family physicians, 18 internists, and 11 cardiologists in 2 Sacramento, Calif, health care systems between January and November 1999, in which 243 new medications were prescribed. We measured the quality of physician communication when prescribing new medications.
RESULTS: Physicians stated the specific medication name for 74% of new prescriptions and explained the purpose of the medication for 87%. Adverse effects were addressed for 35% of medications and how long to take the medication for 34%. Physicians explicitly instructed 55% of patients about the number of tablets to take and explained the frequency or timing of dosing 58% of the time. Physicians fulfilled a mean of 3.1 of 5 expected elements of communication when initiating new prescriptions. They counseled the most about psychiatric medications, fulfilling a mean of 3.7, 3.5, and 3.4, pulmonary, and cardiovascular elements, respectively.
CONCLUSIONS: When initiating new medications, physicians often fail to communicate critical elements of medication use. This might contribute to misunderstandings about medication directions or necessity and, in turn, lead to patient failure to take medications as directed.

Entities:  

Mesh:

Year:  2006        PMID: 17000942     DOI: 10.1001/archinte.166.17.1855

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  109 in total

1.  An EMR-based tool to support collaborative planning for medication use among adults with diabetes: design of a multi-site randomized control trial.

Authors:  Daniel G Morrow; Thembi Conner-Garcia; James F Graumlich; Michael S Wolf; Stacey McKeever; Anna Madison; Kathryn Davis; Elizabeth A H Wilson; Vera Liao; Chieh-Li Chin; Darren Kaiser
Journal:  Contemp Clin Trials       Date:  2012-06-01       Impact factor: 2.226

2.  Provider views about responsibility for medication adherence and content of physician-older patient discussions.

Authors:  Derjung M Tarn; Thomas J Mattimore; Douglas S Bell; Richard L Kravitz; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2012-05-30       Impact factor: 5.562

3.  Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.

Authors:  Julie C Lauffenburger; Joel F Farley; Anil K Gehi; Denise H Rhoney; M Alan Brookhart; Gang Fang
Journal:  Am J Cardiol       Date:  2015-02-02       Impact factor: 2.778

4.  Patient-physicians' information exchange in outpatient cardiac care: time for a heart to heart?

Authors:  Urmimala Sarkar; Dean Schillinger; Kirsten Bibbins-Domingo; Anna Nápoles; Leah Karliner; Eliseo J Pérez-Stable
Journal:  Patient Educ Couns       Date:  2010-10-28

5.  New prescriptions: how well do patients remember important information?

Authors:  Derjung M Tarn; Susan A Flocke
Journal:  Fam Med       Date:  2011-04       Impact factor: 1.756

6.  Adherence to antipsychotics among Latinos and Asians with schizophrenia and limited English proficiency.

Authors:  Todd P Gilmer; Victoria D Ojeda; Concepcion Barrio; Dahlia Fuentes; Piedad Garcia; Nicole M Lanouette; Kelly C Lee
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 3.084

7.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

Review 8.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

9.  Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures.

Authors:  J T Schousboe; B E Dowd; M L Davison; R L Kane
Journal:  Osteoporos Int       Date:  2009-12-05       Impact factor: 4.507

10.  Patients' beliefs and preferences regarding doctors' medication recommendations.

Authors:  Sarah L Goff; Kathleen M Mazor; Vanessa Meterko; Katherine Dodd; James Sabin
Journal:  J Gen Intern Med       Date:  2008-01-18       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.